Loading data for PFE — first visit, this takes a few seconds.

Pfizer Inc. (PFE)

NYSE: PFE · 实时价格 · USD

27.72

+0.07 (0.25%)

收盘价： Sep 11, 2026, 8:01 PM

27.73

+0.04%

盘后: 7:59 PM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

暂无数据

买价	27.69
市值	158B
营收（TTM）	63.7B
净利润（TTM）	4.34B
	0.30
	0.76
	36.47
	9.57
市净率（TTM）	1.85
市销率（TTM）	2.48
财报日期	Nov 3, 2026

卖价	27.72
成交量	25,529,754
20日均量	41,770,066
开盘价	27.80
前收盘价	27.65
日内区间	27.42 - 27.85
52周区间	23.58 - 29.21
分析师	n/a
目标价	n/a
分红	$1.72 (6.22%)
除息日	Jul 24, 2026

关于 PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, N...

[阅读更多]

行业 Drug Manufacturers - General

板块 Healthcare

上市日期 Jun 1, 1972

员工人数 75,000

交易所 NYSE

股票代码 PFE

官网 https://www.pfizer.com

公司完整简介

财务表现

2025年，Pfizer的营收为62.58B，较上一年的63.63B下降-1.65%。净利润为7.77B，下降-3.24%。

财务报表

财报意外

Pfizer 已于 Aug 4, 2026 发布季度财报：

营收为 $15.03B 低于预期 $0, ， 2.60% 同比增长.
每股收益为 0.77 超出预期 0.09, ， -1.28% 同比下滑.

下次财报发布时间

Pfizer Inc. 的下次财报预计于 Nov 3, 2026, 开盘前。
分析师预计营收为 ... 升级

股价变动原因

新闻

1天前 · Kiplinger

15 of the Highest-Yielding Dividend Stocks in the S&P 500

VICI Properties, UPS and General Mills lead the list of the highest-yielding dividend stocks in the S&P 500. Some of the other names might surprise you.

1天前 · Barrons.com

Biohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow.

Biohaven says regulators placed a partial hold on a clinical study for its epilepsy drug candidate, opakalim. One rival drugmaker stands to benefit.

1天前 · MarketBeat

Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot

Novavax (NASDAQ:NVAX) executives outlined the company’s transition from a COVID-19 vaccine-focused business toward a partnership-driven model centered on its Matrix-M adjuvant technology, with near-te...

1天前 · Trefis

JNJ Stock: Is the Rally Running Out of Steam?

A healthcare titan is in a full sprint, but a recent stumble has investors asking if the best part of the race is already over.

2天前 · Trefis

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is ...

第 1 页，共 2 页